Regulation of Akt/FOXO3a/GSK-3β/AR Signaling Network by Isoflavone in Prostate Cancer Cells
Open Access
- 1 October 2008
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (41) , 27707-27716
- https://doi.org/10.1074/jbc.m802759200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cellsOncogene, 2008
- Akt–GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotypeCarcinogenesis: Integrative Cancer Research, 2007
- Soy isoflavones enhance radiotherapy in a metastatic prostate cancer modelInternational Journal of Cancer, 2007
- IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with β-catenin relocalizationJournal of Leukocyte Biology, 2006
- Molecular determinants of Akt-induced keratinocyte transformationOncogene, 2005
- Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementationThe Prostate, 2005
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- PI3K/Akt and apoptosis: size mattersOncogene, 2003
- Alleviating the Suppression of Glycogen Synthase Kinase-3β by Akt Leads to the Phosphorylation of cAMP-response Element-binding Protein and Its Transactivation in Intact Cell NucleiPublished by Elsevier ,2003
- Expression of prostate‐specific antigen is transcriptionally regulated by genistein in prostate cancer cellsMolecular Carcinogenesis, 2002